These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 34727803)

  • 1. Using
    Da Costa CBP; Cruz ACM; Penha JCQ; Castro HC; Da Cunha LER; Ratcliffe NA; Cisne R; Martins FJ
    Expert Opin Drug Discov; 2022 Feb; 17(2):121-137. PubMed ID: 34727803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19.
    Tiwari S; Goel G; Kumar A
    Int Rev Immunol; 2024; 43(1):13-32. PubMed ID: 35757923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferrets: A powerful model of SARS-CoV-2.
    Zhao Y; Wang CL; Gao ZY; Qiao HX; Wang WJ; Liu XY; Chuai X
    Zool Res; 2023 Mar; 44(2):323-330. PubMed ID: 36799224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental Models of COVID-19.
    Caldera-Crespo LA; Paidas MJ; Roy S; Schulman CI; Kenyon NS; Daunert S; Jayakumar AR
    Front Cell Infect Microbiol; 2021; 11():792584. PubMed ID: 35096645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 immunity in animal models.
    Chen Z; Yuan Y; Hu Q; Zhu A; Chen F; Li S; Guan X; Lv C; Tang T; He Y; Cheng J; Zheng J; Hu X; Zhao J; Zhao J; Sun J
    Cell Mol Immunol; 2024 Feb; 21(2):119-133. PubMed ID: 38238440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models and SARS-CoV-2-induced pulmonary and neurological injuries.
    Pinto MA; da Silva ADS; Rodrigues DDRF; Müller R; de Vasconcelos GALBM; Neves PCDC; de Oliveira JM; Marchevsky RS
    Mem Inst Oswaldo Cruz; 2023; 117():e220239. PubMed ID: 36700583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of selected animal models for respiratory coronavirus infection and its application in drug research.
    Qin S; Li R; Zheng Z; Zeng X; Wang Y; Wang X
    J Med Virol; 2022 Jul; 94(7):3032-3042. PubMed ID: 35285034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
    Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
    mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects.
    Wang S; Li L; Yan F; Gao Y; Yang S; Xia X
    Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional modelling of SARS-CoV-2 entry in animal models.
    Brooke GN; Prischi F
    Sci Rep; 2020 Sep; 10(1):15917. PubMed ID: 32985513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models for COVID-19: advances, gaps and perspectives.
    Fan C; Wu Y; Rui X; Yang Y; Ling C; Liu S; Liu S; Wang Y
    Signal Transduct Target Ther; 2022 Jul; 7(1):220. PubMed ID: 35798699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Susceptibility of animal species to experimental SARS-CoV-2 (
    Petrova NV; Ganina KK; Tarasov SA
    Vopr Virusol; 2021 May; 66(2):103-111. PubMed ID: 33993680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
    Toomer G; Burns W; Garcia L; Henry G; Biancofiori A; George A; Duffy C; Chu J; Sides M; Muñoz M; Garcia K; Nikolai-Yogerst A; Peng X; Westfall L; Baker R
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of animal models for COVID-19.
    Qi F; Qin C
    Animal Model Exp Med; 2022 Oct; 5(5):401-409. PubMed ID: 36301011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonhuman primate models for evaluation of SARS-CoV-2 vaccines.
    Neil JA; Griffith M; Godfrey DI; Purcell DFJ; Deliyannis G; Jackson D; Rockman S; Subbarao K; Nolan T
    Expert Rev Vaccines; 2022 Aug; 21(8):1055-1070. PubMed ID: 35652289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge.
    Winkler MS; Skirecki T; Brunkhorst FM; Cajander S; Cavaillon JM; Ferrer R; Flohé SB; García-Salido A; Giamarellos-Bourboulis EJ; Girardis M; Kox M; Lachmann G; Martin-Loeches I; Netea MG; Spinetti T; Schefold JC; Torres A; Uhle F; Venet F; Weis S; Scherag A; Rubio I; Osuchowski MF
    EBioMedicine; 2021 Apr; 66():103291. PubMed ID: 33813139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal Models to Study Emerging Technologies Against SARS-CoV-2.
    Mullick JB; Simmons CS; Gaire J
    Cell Mol Bioeng; 2020 Aug; 13(4):293-303. PubMed ID: 32837584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 infection of Chinese hamsters (Cricetulus griseus) reproduces COVID-19 pneumonia in a well-established small animal model.
    Bertzbach LD; Vladimirova D; Dietert K; Abdelgawad A; Gruber AD; Osterrieder N; Trimpert J
    Transbound Emerg Dis; 2021 May; 68(3):1075-1079. PubMed ID: 32946664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
    Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
    Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of Wuhan-like and omicron-like variants of SARS-CoV-2 in experimental animal models].
    Leneva IA; Smirnova DI; Kartashova NP; Gracheva AV; Ivanina AV; Glubokova EA; Korchevaya ER; Pancratov AA; Trunova GV; Khokhlova VA; Svitich OA; Zverev VV; Faizuloev EB
    Vopr Virusol; 2022 Nov; 67(5):439-449. PubMed ID: 36515289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.